Lars Adamson

783 total citations
27 papers, 666 citations indexed

About

Lars Adamson is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Lars Adamson has authored 27 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 10 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Lars Adamson's work include Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Lars Adamson is often cited by papers focused on Immunotherapy and Immune Responses (16 papers), CAR-T cell therapy research (9 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Lars Adamson collaborates with scholars based in Sweden, United States and Iran. Lars Adamson's co-authors include Rolf Kiessling, Giuseppe Masucci, Birger Blombäck, Isabel Poschke, Yumeng Mao, Roman Procyk, B. Hessel, Flavio Salazar‐Onfray, Håkan Mellstedt and Andreas Lundqvist and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Lars Adamson

27 papers receiving 650 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Adamson Sweden 16 410 279 149 105 63 27 666
Rongqun Guo China 13 253 0.6× 171 0.6× 258 1.7× 88 0.8× 108 1.7× 22 635
Toni Valković Croatia 13 214 0.5× 335 1.2× 194 1.3× 53 0.5× 110 1.7× 42 586
Ana Carolina Leal Brazil 8 270 0.7× 158 0.6× 272 1.8× 49 0.5× 66 1.0× 20 601
Ricardo Grieshaber‐Bouyer Germany 13 389 0.9× 164 0.6× 164 1.1× 46 0.4× 45 0.7× 27 659
Ceri A. Roberts United Kingdom 8 394 1.0× 101 0.4× 124 0.8× 58 0.6× 57 0.9× 10 614
Takashi Igawa Japan 12 332 0.8× 98 0.4× 143 1.0× 44 0.4× 69 1.1× 33 631
Tanja Reineke Switzerland 11 229 0.6× 195 0.7× 174 1.2× 85 0.8× 24 0.4× 15 624
Stephan Kreher Germany 15 251 0.6× 160 0.6× 174 1.2× 37 0.4× 76 1.2× 26 700
Bülent Karagöz Türkiye 11 155 0.4× 168 0.6× 84 0.6× 49 0.5× 27 0.4× 40 439
Michael Conzelmann Germany 10 174 0.4× 144 0.5× 120 0.8× 46 0.4× 160 2.5× 14 500

Countries citing papers authored by Lars Adamson

Since Specialization
Citations

This map shows the geographic impact of Lars Adamson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Adamson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Adamson more than expected).

Fields of papers citing papers by Lars Adamson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Adamson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Adamson. The network helps show where Lars Adamson may publish in the future.

Co-authorship network of co-authors of Lars Adamson

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Adamson. A scholar is included among the top collaborators of Lars Adamson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Adamson. Lars Adamson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Palma, Marzia, Lotta Hansson, Lars Adamson, et al.. (2018). Lenalidomide as immune adjuvant to a dendritic cell vaccine in chronic lymphocytic leukemia patients. European Journal Of Haematology. 101(1). 68–77. 13 indexed citations
2.
Lövgren, Tanja, Dhifaf Sarhan, Iva Truxová, et al.. (2017). Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists. Cancer Immunology Immunotherapy. 66(10). 1333–1344. 30 indexed citations
3.
Laurell, Anna, Maria Lönnemark, Einar Brekkan, et al.. (2017). Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma. Journal for ImmunoTherapy of Cancer. 5(1). 52–52. 47 indexed citations
4.
Gool, Stefaan Van, Stefan Holm, Lars Adamson, et al.. (2016). Immunotherapy in atypical teratoid-rhabdoid tumors: Data from a survey of the HGG-Immuno Group. Cytotherapy. 18(9). 1178–1186. 16 indexed citations
5.
Sarhan, Dhifaf, Marzia Palma, Yumeng Mao, et al.. (2015). Dendritic cell regulation of NK‐cell responses involves lymphotoxin‐α, IL‐12, and TGF‐β. European Journal of Immunology. 45(6). 1783–1793. 30 indexed citations
6.
Poschke, Isabel, Tanja Lövgren, Lars Adamson, et al.. (2014). A phase I clinical trial combining dendritic cell vaccination with adoptive T cell transfer in patients with stage IV melanoma. Cancer Immunology Immunotherapy. 63(10). 1061–1071. 57 indexed citations
7.
Tell, Roger, Lars Adamson, Isabel Poschke, et al.. (2014). A phase I study of adoptive T-cell therapy with or without dendritic cell vaccination in patients with metastatic melanoma.. Journal of Clinical Oncology. 32(15_suppl). TPS3118–TPS3118. 1 indexed citations
8.
Poschke, Isabel, Yumeng Mao, Lars Adamson, et al.. (2011). Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines. Cancer Immunology Immunotherapy. 61(6). 827–838. 109 indexed citations
9.
Palma, Marzia, Lotta Hansson, Aniruddha Choudhury, et al.. (2011). Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria. Cancer Immunology Immunotherapy. 61(6). 865–879. 53 indexed citations
10.
Adamson, Lars, Marzia Palma, A Choudhury, et al.. (2009). Generation of a Dendritic Cell‐based Vaccine in Chronic Lymphocytic Leukaemia Using CliniMACS Platform for Large‐scale Production. Scandinavian Journal of Immunology. 69(6). 529–536. 13 indexed citations
11.
Palma, Marzia, Lars Adamson, Lotta Hansson, et al.. (2008). Development of a dendritic cell-based vaccine for chronic lymphocytic leukemia. Cancer Immunology Immunotherapy. 57(11). 1705–1710. 17 indexed citations
12.
Elliott, Mary Jane, Lars Adamson, Wei Huang, et al.. (2008). PREFERENTIAL DISTRIBUTION OF FOXP3+ REGULATORY T CELLS IN COMPOSITE TISSUE ALLOGRAFTS. Transplantation. 86(2S). 487–487. 26 indexed citations
13.
Adamson, Lars & Erik Walum. (2007). Insulin and IGF-1 Mediated Inhibition of Apoptosis in CHO Cells Grown in Suspension in a Protein-free Medium. Alternatives to Laboratory Animals. 35(3). 349–352. 11 indexed citations
14.
Kokhaei, Parviz, Lars Adamson, Marzia Palma, et al.. (2006). Generation of DC-based vaccine for therapy of B-CLL patients. Comparison of two methods for enriching monocytic precursors. Cytotherapy. 8(4). 318–326. 8 indexed citations
15.
Palmborg, Andreas, Andreas Lundqvist, G B Karlsson, et al.. (2005). Effects of human plasma proteins on maturation of monocyte-derived dendritic cells. Immunology Letters. 100(2). 113–119. 17 indexed citations
16.
Adamson, Lars, Andreas Palmborg, Anna Svensson, et al.. (2004). Development of a technology platform for large-scale clinical grade production of DC. Cytotherapy. 6(4). 363–371. 22 indexed citations
17.
Gustafsson, Helena, et al.. (2001). Insulin-like Growth Factor Type 1 Upregulates Uncoupling Protein 3. Biochemical and Biophysical Research Communications. 287(5). 1105–1111. 16 indexed citations
18.
Hessel, B., et al.. (1987). Fibrinogen Aarhus and factor XIII induced polymerization and gel formation. British Journal of Haematology. 66(3). 355–361. 1 indexed citations
19.
Silveira, Angela, T. Yamamoto, Lars Adamson, B. Hessel, & Birger Blombäck. (1986). Application of an enzyme-linked immunosorbent assay (ELISA) to von willebrand factoR (vWF) and its derivatives. Thrombosis Research. 43(1). 91–102. 35 indexed citations
20.
Procyk, Roman, et al.. (1985). Factor XIII catalyzed formation of fibrinogen-fibronectin oligomers — A thiol enhanced process. Thrombosis Research. 40(6). 833–852. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rongqun Guo Breakdown of academic impact, for papers by Toni Valković Breakdown of academic impact, for papers by Ana Carolina Leal Breakdown of academic impact, for papers by Ricardo Grieshaber‐Bouyer Breakdown of academic impact, for papers by Ceri A. Roberts Breakdown of academic impact, for papers by Takashi Igawa Breakdown of academic impact, for papers by Tanja Reineke Breakdown of academic impact, for papers by Stephan Kreher Breakdown of academic impact, for papers by Bülent Karagöz Breakdown of academic impact, for papers by Michael Conzelmann
Rankless by CCL
2026